← Back to Search

Educational and Empowerment Intervention for High Blood Pressure (TOUCHED Trial)

N/A
Waitlist Available
Led By Heather Prendergast, MD, MPH, MS
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
BP>=140/90 and <=180/110 mm Hg at time of discharge from ED
Verbal fluency in English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month after baseline
Awards & highlights

TOUCHED Trial Summary

This trial is testing an intervention to help people with uncontrolled/undiagnosed hypertension in underrepresented groups. The goal is to see if the intervention lowers blood pressure and improves other measures at 6 months.

Eligible Conditions
  • High Blood Pressure
  • Cardiovascular Disease
  • Vascular Disease

TOUCHED Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

TOUCHED Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month after baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean systolic blood pressure (SBP) difference at 6 months post-intervention compared to usual care.
Secondary outcome measures
Change in cardiovascular risk score/profile.
Hypertensive disease
Diastolic blood pressure
+2 more

TOUCHED Trial Design

2Treatment groups
Active Control
Group I: Usual CareActive Control1 Intervention
Participants randomized to usual care will receive preprinted discharge instructions on HTN and a 48-72-hour referral to our FQHC (or other community health center if pre-assigned though Illinois Medicaid) to schedule their follow-up appointment (current standard of care)
Group II: Educational and Empowerment InterventionActive Control4 Interventions
Participants receive: HTN Educational Video about high BP, how it is diagnosed, and importance of treatment to prevent secondary complications. Visual Echocardiogram Image Clips of age/gender-matched echocardiograms will be used to educate and motivate patients to change behavior and improve their BP. Mobile Health and Remote BP monitoring- participants receive an FDA-approved home blood pressure monitoring (HBPM) kit that includes the Nokia wireless BPM+ monitor and Health Mate mobile app. The app automatically launches when the patient slips on the cuff. Synced data are automatically uploaded from the mobile app to the iCardia server of our study. A Post-Acute Care HTN Transition consultation (PACHT-c) with a clinical pharmacist or advanced practice nurse (APN).

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
602 Previous Clinical Trials
1,557,937 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,814 Previous Clinical Trials
47,290,301 Total Patients Enrolled
Heather Prendergast, MD, MPH, MSPrincipal Investigator - University of Illinois at Chicago
SwedishAmerican Hospital, SwedishAmerican Medical Center-Belvidere, University of Illinois Medical Center at Chicago
University Of Illinois College Of Medicine (Medical School)
University Of Md Medical Sys (Residency)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment seek to include elderly individuals in its population?

"Patients between 18 to 75 years of age may participate in this clinical trial. Conversely, those under the age of 18 must look for one of 122 other trials and individuals over 65 should refer to 1,215 available studies."

Answered by AI

How many people are enrolled in this experiment?

"Affirmative, the clinical trial is still enrolling patients. As evidenced by its most recent update on November 29th 2021, this investigation was first posted to clinicaltrials.gov on February 19th 2019 and requires 570 participants from a single medical centre."

Answered by AI

Has recruitment begun for the current trial program?

"Affirmative. Evidenced on clinicaltrials.gov, this research is actively recruiting patients to participate in their experiment which was first published on February 19th 2019 and updated most recently on November 29th 2021. They are searching for 570 applicants at 1 medical site."

Answered by AI

For whom is enrollment in this investigation suitable?

"This investigation is seeking 570 individuals with vascular issues, aged 18 to 75 years old. Criteria for participation necessitates that patients fulfill the following requirements: Being between 18-75 years of age."

Answered by AI
~94 spots leftby Mar 2025